[Home ] [Archive]   [ فارسی ]  
:: Volume 18, Issue 2 (Scientific Journal of Kurdistan Universiy of Medical Sciences 2013) ::
SJKU 2013, 18(2): 51-57 Back to browse issues page
Prevalence of human T-lymphotropic virus types I&II among high risk groups in Sanandaj in 2010
Naaman Ardalan 1, Mohammad Abdi Dr2, Bahareh Rahimian Zarif Dr1, Amir Amini Dr3, Farzam Meamari 1, Erfan Haydari 1, Abbas Ahmadi 4
1- Islamic Azad University of Sanandaj
2- Tarbiat Modarres University
3- Baqiyatallah University of Medical Sciences
4- Kurdistan University of Medical Sciences , abbasahmady@yahoo.com
Abstract:   (9109 Views)
ABSTRACT Background and Aim: HTLV-I is the etiological cause of adult T-lymphocytic leukemia (ATL) and a chronic degenerative neurologic disorder, called tropical spastic paraparesis (TSP). HTLV infection can be transmitted through different ways: from mother to child or fetus, sexual intercourse, transfusion of contaminated blood or blood products, and sharing contaminated syringe needles. As the presence of these infections in high risk groups can be an approximate indicator of their prevalence in the society and blood donors, in this study was tried to find prevalence of HTLV in HIV positive or negative intravenous drug users (IVDU patients with major thalassemia, and hemodialysis patients, in Sanandaj. Materials and Methods: This descriptive study included 351 cases: 130 HIV positive and 110 HIV negative intravenous drug users (IVDU), 46 cases of major thalassemia, and 65 hemodialysis patients. All participants completed written informed consent forms. After obtaining blood samples and serum separation, all specimens were kept in freezer at -20oC up to the time of analysis. Serum samples were screened for measurement of the titers of HTLV I&II antibodies by Dia-Pro ELISA kits, manufactured in Italy. Positive and suspicious reactions were reanalyzed. For confirmation of positive and suspicious reactions, samples with one positive reaction were examined by use of western blot kid (HTLV blot 2.4, manufactured by MP Diagnostics in Switzerland). Data were entered into SPSS 16 software and the prevalence rates of these viruses were obtained by using frequency distribution table. Results: The results of this study showed that one HIV positive, one HIV negative patient and another patient with major thalassemia were HTLV I positive (0.85%). None of the hemodialysis patients had antibody against HTLV type 1. We did not find any antibody against HTLV type 2 in our study. Conclusions: The prevalence rate of HTLV (types 1 and 2) among these high risk groups was not high in Sanandaj. This may reflect its low prevalence in general population and in blood donors. However, it is necessary to take preventive measures to reduce its spread. To assess the exact prevalence rate we recommend screening of all donated blood samples and general population. Conflict of Interest: Nil Received: May 24, 2012 Accepted: Oct 11, 2012
Keywords: HIV, HTLV I&II, Major thalassemia, Intravenous drug user, Hemodialysis, ELISA, Western Blot
Full-Text [PDF 396 kb]   (1153 Downloads)    
Type of Study: Research | Subject: General
Received: 2013/06/18
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print



Volume 18, Issue 2 (Scientific Journal of Kurdistan Universiy of Medical Sciences 2013) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 3731